A Chinese venture capital firm with offices in Shanghai and Beijing has raised two funds to date, with its second fund raised in 2011 at USD 125 million. The firm mainly invests in early stage high-growth technology businesses but has expanded its interest into medical technology. The firm generally allocates USD 5-10 million per company. The firm focuses 70% domestically and 30% on the US. The firm is interested in companies that have a China angle, specifically, developing products relevant to the Chinese market. The firm is actively seeking new investment opportunities.
In healthcare, the firm is currently looking for medical devices that address a large market in China. IVD and devices with a software component are of high interest. The firm is opportunistic in terms of subsectors and considers all classes of devices. In terms of the stage of development, the firm prefers devices that have regulatory approval (preferably CE mark); ideally, the device should be ready for CFDA. However, the firm will also consider devices in the final stages of clinical trials.
The firm can invest globally but the firm is only interested in companies that have a China angle, i.e. Chinese-led and/or developing products for the Chinese market. The firm has no revenue requirements.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org